Geode Capital Management, LLC Akebia Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,536,292 shares of AKBA stock, worth $6.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,536,292
Previous 1,818,947
149.39%
Holding current value
$6.53 Million
Previous $3.33 Million
39.03%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AKBA
# of Institutions
110Shares Held
55.3MCall Options Held
554KPut Options Held
246K-
Black Rock Inc. New York, NY11.6MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.28MShares$13.4 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$8.28 Million11.5% of portfolio
-
Acadian Asset Management LLC Boston, MA4.06MShares$5.85 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.91MShares$5.64 Million0.01% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $265M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...